Tocilizumab for the Treatment of Ocular Inflammatory Disease.
Tocilizumab for the Treatment of Ocular Inflammatory Disease.
Ocul Immunol Inflamm. 2021 Jan 12;:1-4
Authors: Cunningham ET, Adán A, Nguyen QD, Zierhut M
PMID: 33434090 [PubMed - as supplied by publisher]
Source: Ocular Immunology and Inflammation - Category: Allergy & Immunology Tags: Ocul Immunol Inflamm Source Type: research
More News: Actemra | Allergy & Immunology